Mammalian target of rapamycin (mTOR) kinase inhibitors
- Name
- Mammalian target of rapamycin (mTOR) kinase inhibitors
- Accession Number
- DBCAT005737
- Description
Not Available
- ATC Classification
- Drugs
Drug Drug Description Everolimus A mammalian target of rapamycin (mTOR) kinase inhibitor used to treat various types of malignancies. Ridaforolimus Investigated for use/treatment in solid tumors, sarcoma, cancer/tumors (unspecified), endometrial cancer, prostate cancer, and bone metastases. Temsirolimus A antineoplastic agent used in the treatment of renal cell carcinoma (RCC) that works by inhibiting mTOR. Sirolimus An mTOR inhibitor immunosuppressant used to prevent organ transplant rejections, treat lymphangioleiomyomatosis, and treat adults with perivascular epithelioid cell tumors. - Drugs & Drug Targets